INVO Fertility, Inc. (IVF) - Cash Flow Conversion Efficiency
Based on the latest financial reports, INVO Fertility, Inc. (IVF) has a cash flow conversion efficiency ratio of -0.304x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.78 Million) by net assets ($5.85 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See INVO Fertility, Inc. (IVF) defensive interval to measure how many days the company can operate on defensive assets alone.
INVO Fertility, Inc. - Cash Flow Conversion Efficiency Trend (2006–2024)
This chart illustrates how INVO Fertility, Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.
INVO Fertility, Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of INVO Fertility, Inc. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Nanocap Group AB Series B
ST:NANOC-B
|
N/A |
|
LSL Property Services Plc
LSE:LSL
|
0.034x |
|
NT Minerals Ltd
AU:NTM
|
-0.063x |
|
Inventronics Ltd
V:IVX
|
-0.005x |
|
Sky Gold Corp
V:SKYG
|
-0.256x |
|
Mobile-health Network Solutions Class A Ordinary Shares
NASDAQ:MNDR
|
-0.508x |
|
Asdion Bhd
KLSE:0068
|
0.009x |
|
Artelo Biosciences Inc
NASDAQ:ARTL
|
3.342x |
Annual Cash Flow Conversion Efficiency for INVO Fertility, Inc. (2006–2024)
The table below shows the annual cash flow conversion efficiency of INVO Fertility, Inc. from 2006 to 2024. For the full company profile with market capitalisation and key ratios, see IVF market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $12.75 Million | $-2.97 Million | -0.233x | +95.62% |
| 2023-12-31 | $892.60K | $-4.76 Million | -5.327x | -178.87% |
| 2022-12-31 | $-977.61K | $-6.60 Million | 6.755x | +918.92% |
| 2021-12-31 | $7.31 Million | $-6.03 Million | -0.825x | +0.80% |
| 2020-12-31 | $5.74 Million | $-4.78 Million | -0.831x | -125.29% |
| 2019-12-31 | $-3.71 Million | $1.37 Million | -0.369x | -253.97% |
| 2018-12-31 | $-2.72 Million | $-652.97K | 0.240x | +560.10% |
| 2017-12-31 | $-4.99 Million | $-181.27K | 0.036x | -48.23% |
| 2016-12-31 | $-4.62 Million | $-323.90K | 0.070x | +73.81% |
| 2015-12-31 | $-3.76 Million | $-151.62K | 0.040x | +806.74% |
| 2014-12-31 | $-4.36 Million | $-19.40K | 0.004x | -71.66% |
| 2013-12-31 | $-3.81 Million | $-59.92K | 0.016x | +22.60% |
| 2012-12-31 | $-3.37 Million | $-43.21K | 0.013x | -68.18% |
| 2011-12-31 | $-2.93 Million | $-117.78K | 0.040x | -68.38% |
| 2010-12-31 | $-2.48 Million | $-315.99K | 0.127x | -57.65% |
| 2009-12-31 | $-3.08 Million | $-926.66K | 0.301x | -93.61% |
| 2008-12-31 | $-226.57K | $-1.07 Million | 4.708x | +309.46% |
| 2007-12-31 | $-100.93K | $-116.04K | 1.150x | +4369.14% |
| 2006-12-31 | $37.54K | $-1.01K | -0.027x | -- |
About INVO Fertility, Inc.
INVO Fertility, Inc., a healthcare services company, focuses on the fertility marketplace that provides assisted reproductive technology care to patients. It operates through Fertility Clinic Services; INVOcell Device; and Therapeutics segments. The company offers INVOcell Device, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body… Read more